Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury

BACKGROUND/AIM: Acute lung injury (ALI) is a major cause of death in the intensive care unit. Lipopolysaccharide (LPS) induced lung injury is the most widely used experimental ALI model and provides opportunities for new targeting therapy. In this study, we investigated the effects of tocilizumab, a...

Descripción completa

Detalles Bibliográficos
Autores principales: SARIOĞLU, Nurhan, SUNAY, Fatma Bahar, YAY, Arzu, KORKUT, Oğuzhan, EREL, Fuat, HİŞMİOĞULLARI, Adnan Adil, KÖSE, Mehmet, YALÇIN, Betül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742495/
https://www.ncbi.nlm.nih.gov/pubmed/34217170
http://dx.doi.org/10.3906/sag-2010-303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742495/
https://www.ncbi.nlm.nih.gov/pubmed/34217170
http://dx.doi.org/10.3906/sag-2010-303

Ejemplares similares